nodes	percent_of_prediction	percent_of_DWPC	metapath
Gonadorelin—Ovarian disorder—Ifosfamide—testicular cancer	0.112	0.112	CcSEcCtD
Gonadorelin—Thromboembolism—Epirubicin—testicular cancer	0.0242	0.0242	CcSEcCtD
Gonadorelin—Thromboembolism—Doxorubicin—testicular cancer	0.0224	0.0224	CcSEcCtD
Gonadorelin—Pain—Carboplatin—testicular cancer	0.0156	0.0156	CcSEcCtD
Gonadorelin—Embolism venous—Epirubicin—testicular cancer	0.0153	0.0153	CcSEcCtD
Gonadorelin—Swelling—Ifosfamide—testicular cancer	0.0143	0.0143	CcSEcCtD
Gonadorelin—Embolism venous—Doxorubicin—testicular cancer	0.0141	0.0141	CcSEcCtD
Gonadorelin—Embolism—Methotrexate—testicular cancer	0.0128	0.0128	CcSEcCtD
Gonadorelin—Pelvic pain—Epirubicin—testicular cancer	0.0127	0.0127	CcSEcCtD
Gonadorelin—Embolism—Epirubicin—testicular cancer	0.012	0.012	CcSEcCtD
Gonadorelin—Pelvic pain—Doxorubicin—testicular cancer	0.0117	0.0117	CcSEcCtD
Gonadorelin—Breast disorder—Ifosfamide—testicular cancer	0.0114	0.0114	CcSEcCtD
Gonadorelin—Redness—Epirubicin—testicular cancer	0.0114	0.0114	CcSEcCtD
Gonadorelin—Swelling—Etoposide—testicular cancer	0.0113	0.0113	CcSEcCtD
Gonadorelin—Embolism—Doxorubicin—testicular cancer	0.0111	0.0111	CcSEcCtD
Gonadorelin—Redness—Doxorubicin—testicular cancer	0.0106	0.0106	CcSEcCtD
Gonadorelin—Breast disorder—Cisplatin—testicular cancer	0.00984	0.00984	CcSEcCtD
Gonadorelin—Abdominal discomfort—Cisplatin—testicular cancer	0.00902	0.00902	CcSEcCtD
Gonadorelin—Erythema—Bleomycin—testicular cancer	0.0089	0.0089	CcSEcCtD
Gonadorelin—Breast pain—Epirubicin—testicular cancer	0.00883	0.00883	CcSEcCtD
Gonadorelin—Erythema—Dactinomycin—testicular cancer	0.0083	0.0083	CcSEcCtD
Gonadorelin—Breast pain—Doxorubicin—testicular cancer	0.00817	0.00817	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Chlorambucil—testicular cancer	0.0081	0.0081	CcSEcCtD
Gonadorelin—Fatigue—Chlorambucil—testicular cancer	0.00809	0.00809	CcSEcCtD
Gonadorelin—Pain—Chlorambucil—testicular cancer	0.00802	0.00802	CcSEcCtD
Gonadorelin—Angiopathy—Ifosfamide—testicular cancer	0.00792	0.00792	CcSEcCtD
Gonadorelin—Immune system disorder—Ifosfamide—testicular cancer	0.00789	0.00789	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Chlorambucil—testicular cancer	0.00767	0.00767	CcSEcCtD
Gonadorelin—Injection site reaction—Epirubicin—testicular cancer	0.00765	0.00765	CcSEcCtD
Gonadorelin—Erythema—Ifosfamide—testicular cancer	0.0076	0.0076	CcSEcCtD
Gonadorelin—Abdominal pain—Chlorambucil—testicular cancer	0.00742	0.00742	CcSEcCtD
Gonadorelin—Pain—Vinblastine—testicular cancer	0.00735	0.00735	CcSEcCtD
Gonadorelin—Constipation—Vinblastine—testicular cancer	0.00735	0.00735	CcSEcCtD
Gonadorelin—Anaphylactic shock—Bleomycin—testicular cancer	0.00726	0.00726	CcSEcCtD
Gonadorelin—Injection site reaction—Doxorubicin—testicular cancer	0.00708	0.00708	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Vinblastine—testicular cancer	0.00703	0.00703	CcSEcCtD
Gonadorelin—Hypersensitivity—Chlorambucil—testicular cancer	0.00691	0.00691	CcSEcCtD
Gonadorelin—Immune system disorder—Cisplatin—testicular cancer	0.0068	0.0068	CcSEcCtD
Gonadorelin—Abdominal pain—Vinblastine—testicular cancer	0.0068	0.0068	CcSEcCtD
Gonadorelin—Asthenia—Chlorambucil—testicular cancer	0.00673	0.00673	CcSEcCtD
Gonadorelin—Pruritus—Chlorambucil—testicular cancer	0.00664	0.00664	CcSEcCtD
Gonadorelin—Erythema—Cisplatin—testicular cancer	0.00655	0.00655	CcSEcCtD
Gonadorelin—Flatulence—Cisplatin—testicular cancer	0.00646	0.00646	CcSEcCtD
Gonadorelin—Diarrhoea—Chlorambucil—testicular cancer	0.00642	0.00642	CcSEcCtD
Gonadorelin—Hypersensitivity—Vinblastine—testicular cancer	0.00633	0.00633	CcSEcCtD
Gonadorelin—Angiopathy—Etoposide—testicular cancer	0.00626	0.00626	CcSEcCtD
Gonadorelin—Immune system disorder—Etoposide—testicular cancer	0.00623	0.00623	CcSEcCtD
Gonadorelin—Pain—Bleomycin—testicular cancer	0.00621	0.00621	CcSEcCtD
Gonadorelin—Anaphylactic shock—Ifosfamide—testicular cancer	0.00621	0.00621	CcSEcCtD
Gonadorelin—Asthenia—Vinblastine—testicular cancer	0.00617	0.00617	CcSEcCtD
Gonadorelin—Nervous system disorder—Ifosfamide—testicular cancer	0.00609	0.00609	CcSEcCtD
Gonadorelin—Vomiting—Chlorambucil—testicular cancer	0.00596	0.00596	CcSEcCtD
Gonadorelin—Diarrhoea—Vinblastine—testicular cancer	0.00588	0.00588	CcSEcCtD
Gonadorelin—Fatigue—Dactinomycin—testicular cancer	0.00584	0.00584	CcSEcCtD
Gonadorelin—Pain—Dactinomycin—testicular cancer	0.00579	0.00579	CcSEcCtD
Gonadorelin—Nausea—Chlorambucil—testicular cancer	0.00557	0.00557	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Dactinomycin—testicular cancer	0.00554	0.00554	CcSEcCtD
Gonadorelin—Vomiting—Vinblastine—testicular cancer	0.00547	0.00547	CcSEcCtD
Gonadorelin—Breast disorder—Methotrexate—testicular cancer	0.0054	0.0054	CcSEcCtD
Gonadorelin—Headache—Vinblastine—testicular cancer	0.00539	0.00539	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.00536	0.00536	CcSEcCtD
Gonadorelin—Abdominal pain—Dactinomycin—testicular cancer	0.00535	0.00535	CcSEcCtD
Gonadorelin—Fatigue—Ifosfamide—testicular cancer	0.00535	0.00535	CcSEcCtD
Gonadorelin—Anaphylactic shock—Cisplatin—testicular cancer	0.00535	0.00535	CcSEcCtD
Gonadorelin—Hypersensitivity—Bleomycin—testicular cancer	0.00535	0.00535	CcSEcCtD
Gonadorelin—Constipation—Ifosfamide—testicular cancer	0.00531	0.00531	CcSEcCtD
Gonadorelin—Pain—Ifosfamide—testicular cancer	0.00531	0.00531	CcSEcCtD
Gonadorelin—Nervous system disorder—Cisplatin—testicular cancer	0.00525	0.00525	CcSEcCtD
Gonadorelin—Asthenia—Bleomycin—testicular cancer	0.00521	0.00521	CcSEcCtD
Gonadorelin—Pruritus—Bleomycin—testicular cancer	0.00514	0.00514	CcSEcCtD
Gonadorelin—Nausea—Vinblastine—testicular cancer	0.00511	0.00511	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Ifosfamide—testicular cancer	0.00507	0.00507	CcSEcCtD
Gonadorelin—Breast disorder—Epirubicin—testicular cancer	0.00505	0.00505	CcSEcCtD
Gonadorelin—Hypersensitivity—Dactinomycin—testicular cancer	0.00499	0.00499	CcSEcCtD
Gonadorelin—Abdominal discomfort—Methotrexate—testicular cancer	0.00495	0.00495	CcSEcCtD
Gonadorelin—Abdominal pain—Ifosfamide—testicular cancer	0.00491	0.00491	CcSEcCtD
Gonadorelin—Anaphylactic shock—Etoposide—testicular cancer	0.0049	0.0049	CcSEcCtD
Gonadorelin—Asthenia—Dactinomycin—testicular cancer	0.00486	0.00486	CcSEcCtD
Gonadorelin—Upper respiratory tract infection—Methotrexate—testicular cancer	0.0048	0.0048	CcSEcCtD
Gonadorelin—Breast disorder—Doxorubicin—testicular cancer	0.00467	0.00467	CcSEcCtD
Gonadorelin—Diarrhoea—Dactinomycin—testicular cancer	0.00463	0.00463	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Cisplatin—testicular cancer	0.00462	0.00462	CcSEcCtD
Gonadorelin—Vomiting—Bleomycin—testicular cancer	0.00462	0.00462	CcSEcCtD
Gonadorelin—Pain—Cisplatin—testicular cancer	0.00457	0.00457	CcSEcCtD
Gonadorelin—Hypersensitivity—Ifosfamide—testicular cancer	0.00457	0.00457	CcSEcCtD
Gonadorelin—Upper respiratory tract infection—Epirubicin—testicular cancer	0.00449	0.00449	CcSEcCtD
Gonadorelin—Asthenia—Ifosfamide—testicular cancer	0.00445	0.00445	CcSEcCtD
Gonadorelin—Pruritus—Ifosfamide—testicular cancer	0.00439	0.00439	CcSEcCtD
Gonadorelin—Nausea—Bleomycin—testicular cancer	0.00431	0.00431	CcSEcCtD
Gonadorelin—Vomiting—Dactinomycin—testicular cancer	0.00431	0.00431	CcSEcCtD
Gonadorelin—Diarrhoea—Ifosfamide—testicular cancer	0.00425	0.00425	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Etoposide—testicular cancer	0.00423	0.00423	CcSEcCtD
Gonadorelin—Fatigue—Etoposide—testicular cancer	0.00423	0.00423	CcSEcCtD
Gonadorelin—Constipation—Etoposide—testicular cancer	0.00419	0.00419	CcSEcCtD
Gonadorelin—Pain—Etoposide—testicular cancer	0.00419	0.00419	CcSEcCtD
Gonadorelin—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.00415	0.00415	CcSEcCtD
Gonadorelin—Nausea—Dactinomycin—testicular cancer	0.00402	0.00402	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Etoposide—testicular cancer	0.00401	0.00401	CcSEcCtD
Gonadorelin—Vomiting—Ifosfamide—testicular cancer	0.00395	0.00395	CcSEcCtD
Gonadorelin—Hypersensitivity—Cisplatin—testicular cancer	0.00394	0.00394	CcSEcCtD
Gonadorelin—Abdominal pain—Etoposide—testicular cancer	0.00387	0.00387	CcSEcCtD
Gonadorelin—Asthenia—Cisplatin—testicular cancer	0.00384	0.00384	CcSEcCtD
Gonadorelin—Angiopathy—Methotrexate—testicular cancer	0.00375	0.00375	CcSEcCtD
Gonadorelin—Immune system disorder—Methotrexate—testicular cancer	0.00373	0.00373	CcSEcCtD
Gonadorelin—Nausea—Ifosfamide—testicular cancer	0.00369	0.00369	CcSEcCtD
Gonadorelin—Diarrhoea—Cisplatin—testicular cancer	0.00366	0.00366	CcSEcCtD
Gonadorelin—Hypersensitivity—Etoposide—testicular cancer	0.00361	0.00361	CcSEcCtD
Gonadorelin—Erythema—Methotrexate—testicular cancer	0.0036	0.0036	CcSEcCtD
Gonadorelin—Asthenia—Etoposide—testicular cancer	0.00352	0.00352	CcSEcCtD
Gonadorelin—Angiopathy—Epirubicin—testicular cancer	0.00351	0.00351	CcSEcCtD
Gonadorelin—Immune system disorder—Epirubicin—testicular cancer	0.00349	0.00349	CcSEcCtD
Gonadorelin—Pruritus—Etoposide—testicular cancer	0.00347	0.00347	CcSEcCtD
Gonadorelin—Vomiting—Cisplatin—testicular cancer	0.0034	0.0034	CcSEcCtD
Gonadorelin—Erythema—Epirubicin—testicular cancer	0.00337	0.00337	CcSEcCtD
Gonadorelin—Diarrhoea—Etoposide—testicular cancer	0.00335	0.00335	CcSEcCtD
Gonadorelin—Flatulence—Epirubicin—testicular cancer	0.00332	0.00332	CcSEcCtD
Gonadorelin—Angiopathy—Doxorubicin—testicular cancer	0.00325	0.00325	CcSEcCtD
Gonadorelin—Immune system disorder—Doxorubicin—testicular cancer	0.00323	0.00323	CcSEcCtD
Gonadorelin—Nausea—Cisplatin—testicular cancer	0.00318	0.00318	CcSEcCtD
Gonadorelin—Vomiting—Etoposide—testicular cancer	0.00312	0.00312	CcSEcCtD
Gonadorelin—Erythema—Doxorubicin—testicular cancer	0.00311	0.00311	CcSEcCtD
Gonadorelin—Headache—Etoposide—testicular cancer	0.00307	0.00307	CcSEcCtD
Gonadorelin—Flatulence—Doxorubicin—testicular cancer	0.00307	0.00307	CcSEcCtD
Gonadorelin—Anaphylactic shock—Methotrexate—testicular cancer	0.00294	0.00294	CcSEcCtD
Gonadorelin—Nausea—Etoposide—testicular cancer	0.00291	0.00291	CcSEcCtD
Gonadorelin—Nervous system disorder—Methotrexate—testicular cancer	0.00288	0.00288	CcSEcCtD
Gonadorelin—Anaphylactic shock—Epirubicin—testicular cancer	0.00275	0.00275	CcSEcCtD
Gonadorelin—Shock—Epirubicin—testicular cancer	0.0027	0.0027	CcSEcCtD
Gonadorelin—Nervous system disorder—Epirubicin—testicular cancer	0.00269	0.00269	CcSEcCtD
Gonadorelin—Anaphylactic shock—Doxorubicin—testicular cancer	0.00254	0.00254	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Methotrexate—testicular cancer	0.00253	0.00253	CcSEcCtD
Gonadorelin—Fatigue—Methotrexate—testicular cancer	0.00253	0.00253	CcSEcCtD
Gonadorelin—Pain—Methotrexate—testicular cancer	0.00251	0.00251	CcSEcCtD
Gonadorelin—Shock—Doxorubicin—testicular cancer	0.0025	0.0025	CcSEcCtD
Gonadorelin—Nervous system disorder—Doxorubicin—testicular cancer	0.00249	0.00249	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Methotrexate—testicular cancer	0.0024	0.0024	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Epirubicin—testicular cancer	0.00237	0.00237	CcSEcCtD
Gonadorelin—Fatigue—Epirubicin—testicular cancer	0.00237	0.00237	CcSEcCtD
Gonadorelin—Pain—Epirubicin—testicular cancer	0.00235	0.00235	CcSEcCtD
Gonadorelin—Constipation—Epirubicin—testicular cancer	0.00235	0.00235	CcSEcCtD
Gonadorelin—Abdominal pain—Methotrexate—testicular cancer	0.00232	0.00232	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Epirubicin—testicular cancer	0.00225	0.00225	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.00219	0.00219	CcSEcCtD
Gonadorelin—Fatigue—Doxorubicin—testicular cancer	0.00219	0.00219	CcSEcCtD
Gonadorelin—Pain—Doxorubicin—testicular cancer	0.00217	0.00217	CcSEcCtD
Gonadorelin—Constipation—Doxorubicin—testicular cancer	0.00217	0.00217	CcSEcCtD
Gonadorelin—Abdominal pain—Epirubicin—testicular cancer	0.00217	0.00217	CcSEcCtD
Gonadorelin—Hypersensitivity—Methotrexate—testicular cancer	0.00216	0.00216	CcSEcCtD
Gonadorelin—Asthenia—Methotrexate—testicular cancer	0.00211	0.00211	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Doxorubicin—testicular cancer	0.00208	0.00208	CcSEcCtD
Gonadorelin—Pruritus—Methotrexate—testicular cancer	0.00208	0.00208	CcSEcCtD
Gonadorelin—Hypersensitivity—Epirubicin—testicular cancer	0.00202	0.00202	CcSEcCtD
Gonadorelin—Abdominal pain—Doxorubicin—testicular cancer	0.00201	0.00201	CcSEcCtD
Gonadorelin—Diarrhoea—Methotrexate—testicular cancer	0.00201	0.00201	CcSEcCtD
Gonadorelin—Asthenia—Epirubicin—testicular cancer	0.00197	0.00197	CcSEcCtD
Gonadorelin—Pruritus—Epirubicin—testicular cancer	0.00194	0.00194	CcSEcCtD
Gonadorelin—Diarrhoea—Epirubicin—testicular cancer	0.00188	0.00188	CcSEcCtD
Gonadorelin—Hypersensitivity—Doxorubicin—testicular cancer	0.00187	0.00187	CcSEcCtD
Gonadorelin—Vomiting—Methotrexate—testicular cancer	0.00187	0.00187	CcSEcCtD
Gonadorelin—Headache—Methotrexate—testicular cancer	0.00184	0.00184	CcSEcCtD
Gonadorelin—Asthenia—Doxorubicin—testicular cancer	0.00182	0.00182	CcSEcCtD
Gonadorelin—Pruritus—Doxorubicin—testicular cancer	0.0018	0.0018	CcSEcCtD
Gonadorelin—Vomiting—Epirubicin—testicular cancer	0.00175	0.00175	CcSEcCtD
Gonadorelin—Nausea—Methotrexate—testicular cancer	0.00174	0.00174	CcSEcCtD
Gonadorelin—Diarrhoea—Doxorubicin—testicular cancer	0.00174	0.00174	CcSEcCtD
Gonadorelin—Headache—Epirubicin—testicular cancer	0.00172	0.00172	CcSEcCtD
Gonadorelin—Nausea—Epirubicin—testicular cancer	0.00163	0.00163	CcSEcCtD
Gonadorelin—Vomiting—Doxorubicin—testicular cancer	0.00162	0.00162	CcSEcCtD
Gonadorelin—Headache—Doxorubicin—testicular cancer	0.00159	0.00159	CcSEcCtD
Gonadorelin—Nausea—Doxorubicin—testicular cancer	0.00151	0.00151	CcSEcCtD
